EBS

Emergent BioSolutions Inc.

Sector: healthcareDrug Manufacturers - Specialty & GenericNYSEMarket Cap: $583.1M

Emergent BioSolutions Inc. is a biopharmaceutical company focused on public health threats, with its primary political signal being $1.37M in disclosed payments to healthcare professionals from 2020-2024, against a backdrop of minimal federal contracting ($236K) and no recent insider or congressional trading.

Govt Dependence

85/100

Regulatory Density

90/100

Lobbying Intensity

0/100

Political Signal

NEUTRAL

BusinessWhat EBS does

Emergent BioSolutions develops, manufactures, and provides medical countermeasures for public health threats, including vaccines and therapeutics for infectious diseases and chemical, biological, radiological, and nuclear (CBRN) threats. Its revenue is heavily tied to government procurement contracts and grants for biodefense and pandemic preparedness products. The company's financial performance is closely linked to U.S. government funding cycles and public health emergency declarations.

12 months past · 3 months futureEBS activity timeline

Congress

buy sell

Insider · Form 4

open-market buy

Hedge fund · 13F

opened + added − trimmed closed holds

Bills

past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)

240 trading days · 0 congressional trades shown · 0 insider buys · 12 13F filings · 0 past bill actions · 16 upcoming markups

Lifetime Government AwardsEBS federal contracts by year

$236K

total awarded · 2021–2023

contracts on file

2021

peak year ($127K)

Top contracts by award amount

$123K Department of Defense 2021-06-03 8508231182!REACTIVE SKIN DECON

$108K Department of Defense 2023-01-11 8509633281!REACTIVE SKIN DECON

$4K Department of Defense 2021-08-02 8508283491!TRAINING AID,REACTI

3 years · 3 contracts

Smart Money · 13F HoldingsHedge funds holding EBS

$94.3M

Total EBS held by tracked 13F funds

Funds with EBS positions

+33

Funds opened this quarter

Two Sigma Investments $8M opened 2024-12-31

Renaissance Technologies $7M opened 2025-12-31

D.E. Shaw & Co. $7M opened 2025-12-31

Renaissance Technologies $6M opened 2024-12-31

Two Sigma Investments $6M opened 2024-09-30

D.E. Shaw & Co. $6M opened 2024-09-30

Renaissance Technologies $5M opened 2025-09-30

Renaissance Technologies $4M opened 2025-06-30

25 more 13F positions tracked · quarterly delta charts available in member dashboard

Politicians Trading EBSMembers of Congress with recent EBS positions

1 politicians traded EBS across 2 disclosed transactions totaling $16K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just EBS). 0-30 LOW · 30-60 MID · 60+ HIGH.

Steve Cohen D-Tennessee · house 2 sells $16K 2024-12-11 LOW · 2

Congressional TradesWho in Congress is trading EBS

2024-12-11 Steve Cohen D-Tennessee · house Sale $1,001 - $15,000

2024-12-11 Steve Cohen D-Tennessee · house sale $1,001 - $15,000

2021-11-05 Josh Gottheimer D-New Jersey · house Sale $1,001 - $15,000

2021-11-05 Josh Gottheimer D-New Jersey · house sale $1,001 - $15,000

2021-10-18 Josh Gottheimer D-New Jersey · house Purchase $1,001 - $15,000

2021-10-18 Josh Gottheimer D-New Jersey · house purchase $1,001 - $15,000

2021-09-15 Josh Gottheimer D-New Jersey · house Sale $1,001 - $15,000

2021-09-15 Josh Gottheimer D-New Jersey · house sale $1,001 - $15,000

2021-02-23 Josh Gottheimer D-New Jersey · house sale $1,001 - $15,000

2021-02-23 Josh Gottheimer D-New Jersey · house Sale $1,001 - $15,000

2020-11-24 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000

2020-11-24 Gilbert Ray Cisneros D-California · house purchase $1,001 - $15,000

26+ trades on file · most recent 2025-01-10

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

No Form 4 activity recorded in the last 180 days.

Political ProfileWhere EBS sits in Washington

[object Object]

STRUCTURAL: High government dependence (85) and regulatory density (90) scores are inherent to the biodefense sector, but no lobbying spend (`get_political_influence.lobbying.total_income` = 0) or aligned congressional champions are present. EVIDENTIARY: No recent corporate insider buys (`get_corporate_insider_signal.total_buys` = 0), no congressional trades, and only minimal, non-recurring federal contract obligations ($236K). The $1.37M in doctor payments is a compliance signal, not a directional political one. Net: Structural exposure is not currently matched by evidentiary support from market participants.

Regulatory ExposureThreats & opportunities

Regulatory threats

Scrutiny of payments to healthcare professionals (HCPs) for promotional activities.

Department of Health and Human Services (HHS)

"`get_political_influence.doctor_payments` shows $1.37M in payments to HCPs from 2020-2024, which are publicly disclosed under the Sunshine Act and subject to regulatory review."

Regulatory opportunities

Renewal or expansion of biodefense procurement contracts from the Department of Defense.

Department of Defense (DoD)

"`get_government_precedent.federal_contracts_summary[0]` shows three existing contracts totaling $235,852.90 with the DoD, establishing a procurement precedent."

Member intelligence layer

Live signals + predictions for EBS — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Live 7-layer signal scores when Congress trades EBS
Bill Pass Index v2 odds for every bill on the watch list
Iron Triangle alerts (committee × donor × trade)
SEC Form 4 cluster detection (CEO + CFO + director buys)
Whale-Opportunity expected-value ranking
Custom watchlist alerts via email + Discord

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout EBS & political exposure

Does Emergent BioSolutions Inc. (EBS) hold federal contracts?

Yes. Emergent BioSolutions Inc. has 3 federal contract awards totaling $235,853, primarily from agencies including Department of Defense. See full contract list and amounts on this page.

Has Congress traded EBS stock?

26 congressional trades by 3 unique members of Congress, most recently on 2024-12-11. See the Congressional Trading panel for politician-by-politician breakdown.

What is EBS political risk profile?

Government dependence: 85/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.

How does GovGreed track EBS political activity?

GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. EBS data is updated daily from these official federal sources.